Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8327)
All Articles published online
|
Publishing Process of This Article
|
Mar 21, 2014 (publication date) through Apr 9, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | He J, Zeng ZC, Xiang ZL, Yang P. Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis. World J Gastroenterol 2014; 20(11): 3025-3032 [PMID: 24659894 DOI: 10.3748/wjg.v20.i11.3025] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i11/3025.htm |
| Number | Citing Articles |
| 1 |
J-Y Guo, H-S Hsu, S-W Tyan, F-Y Li, J-Y Shew, W-H Lee, J-Y Chen. Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner. Oncogene 2017; 36(17): 2457 doi: 10.1038/onc.2016.404
|
| 2 |
Chibo Liu, Yanqun Cai, Sihua Mou. Liquid biopsy in lung cancer: The role of circulating tumor cells in diagnosis, treatment, and prognosis. Biomedicine & Pharmacotherapy 2024; 181: 117726 doi: 10.1016/j.biopha.2024.117726
|
| 3 |
Dragana Nikitovic, Aikaterini Berdiaki, Ioanna Spyridaki, Theodoros Krasanakis, Aristidis Tsatsakis, George N. Tzanakakis. Proteoglycans—Biomarkers and Targets in Cancer Therapy. Frontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00069
|
| 4 |
Nathia Nathaly Rigoglio, Ana Carolina Silveira Rabelo, Jessica Borghesi, Gustavo de Sá Schiavo Matias, Paula Fratini, Pedro Henrique Dias Moura Prazeres, Concepta Margaret Mc Manus Pimentel, Alexander Birbrair, Maria Angelica Miglino. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2020; 1245: 1 doi: 10.1007/978-3-030-40146-7_1
|
| 5 |
Yanbing Chen, Ying Zhu, Yanling Sheng, Juhua Xiao, Yu Xiao, Na Cheng, Yong Chai, Xiaoping Wu, Shouhua Zhang, Tianxin Xiang. SIRT1 downregulated FGB expression to inhibit RCC tumorigenesis by destabilizing STAT3. Experimental Cell Research 2019; 382(2): 111466 doi: 10.1016/j.yexcr.2019.06.011
|
| 6 |
Yuan Zhang, Xiaorong Chen, Yajuan Cao, Zongguo Yang. C8B in Complement and Coagulation Cascades Signaling Pathway is a predictor for Survival in HBV-Related Hepatocellular Carcinoma Patients. Cancer Management and Research 2021; : 3503 doi: 10.2147/CMAR.S302917
|
| 7 |
Yasuo Tanaka, Ryosuke Tateishi, Kazuhiko Koike. Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2018; 19(10): 3070 doi: 10.3390/ijms19103070
|
| 8 |
Zixing Xu, Wantong Zhang, Nianrong Sun, Chunhui Deng. Magnetic mesoporous materials and MALDI-TOF MS in peptidomics: From enrichment techniques to disease applications. TrAC Trends in Analytical Chemistry 2024; 175: 117725 doi: 10.1016/j.trac.2024.117725
|
| 9 |
Dimitra Manou, Nikos K. Karamanos, Achilleas D. Theocharis. Tumorigenic functions of serglycin: Regulatory roles in epithelial to mesenchymal transition and oncogenic signaling. Seminars in Cancer Biology 2020; 62: 108 doi: 10.1016/j.semcancer.2019.07.004
|
| 10 |
Yun Zhu, Annie Lai Man Cheung. Proteoglycans and their functions in esophageal squamous cell carcinoma. World Journal of Clinical Oncology 2021; 12(7): 507-521 doi: 10.5306/wjco.v12.i7.507
|
| 11 |
Lucia Cerrito, Maria Elena Ainora, Carolina Mosoni, Raffaele Borriello, Antonio Gasbarrini, Maria Assunta Zocco. Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy. Cancers 2022; 14(19): 4647 doi: 10.3390/cancers14194647
|
| 12 |
Joanna Hajduk, Jan Matysiak, Zenon J. Kokot. Challenges in biomarker discovery with MALDI-TOF MS. Clinica Chimica Acta 2016; 458: 84 doi: 10.1016/j.cca.2016.04.033
|
| 13 |
Xiaofeng Yuan, Ming Zhuang, Xi Zhu, Dong Cheng, Jie Liu, Donglin Sun, Xubin Qiu, Yunjie Lu, Kurt Sartorius. Emerging Perspectives of Bone Metastasis in Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.943866
|
| 14 |
Theresa D. Ahrens, Sara R. Bang-Christensen, Amalie M. Jørgensen, Caroline Løppke, Charlotte B. Spliid, Nicolai T. Sand, Thomas M. Clausen, Ali Salanti, Mette Ø. Agerbæk. The Role of Proteoglycans in Cancer Metastasis and Circulating Tumor Cell Analysis. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00749
|
| 15 |
Lin Li, Jing Wu, Christopher J. Lyon, Li Jiang, Tony Y. Hu. Clinical Peptidomics: Advances in Instrumentation, Analyses, and Applications. BME Frontiers 2023; 4 doi: 10.34133/bmef.0019
|
| 16 |
Jan Matysiak, Agata Światły, Joanna Hajduk, Joanna Matysiak, Zenon Kokot. Influence of Honeybee Sting on Peptidome Profile in Human Serum. Toxins 2015; 7(5): 1808 doi: 10.3390/toxins7051808
|
| 17 |
Bo Li, Boan Li, Tongsheng Guo, Zhiqiang Sun, Xiaohan Li, Xiaoxi Li, Han Wang, Weijiao Chen, Peng Chen, Mengran Qiao, Lifang Xia, Yuanli Mao. Application Value of Mass Spectrometry in the Differentiation of Benign and Malignant Liver Tumors. Medical Science Monitor 2017; 23: 1636 doi: 10.12659/MSM.901064
|
| 18 |
凡 李. The Research Progress in Bone Metastasis of Hepatocellular Carcinoma. Advances in Clinical Medicine 2022; 12(06): 5434 doi: 10.12677/ACM.2022.126787
|
| 19 |
Ju Bai, Aili He, Chen Huang, Juan Yang, Wanggang Zhang, Jianli Wang, Yun Yang, Pengyu Zhang, Yang Zhang, Fuling Zhou. Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia. Proteome Science 2014; 12(1) doi: 10.1186/s12953-014-0049-y
|